The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target

被引:39
作者
Yang, Yun [1 ]
Ye, Wen-Long [1 ]
Zhang, Ruo-Nan [1 ,2 ]
He, Xiao-Shun [2 ]
Wang, Jing-Ru [2 ]
Liu, Yu-Xuan [1 ]
Wang, Yi [1 ]
Yang, Xue-Mei [1 ,2 ]
Zhang, Yu-Juan [1 ]
Gan, Wen-Juan [3 ]
机构
[1] Soochow Univ, Med Coll, Dept Pathol, Suzhou 215123, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Dept Pathol, Suzhou 215123, Peoples R China
[3] Soochow Univ, Dushu Lake Hosp, Dept Pathol, Suzhou 215123, Peoples R China
基金
中国国家自然科学基金;
关键词
GROWTH-FACTOR-BETA; FYVE DOMAIN PROTEIN; SQUAMOUS-CELL CARCINOMA; RECEPTOR-I; TRANSFORMING GROWTH-FACTOR-BETA-1; MYOFIBROBLAST DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; MULTIPLE FUNCTIONS; ACTIVATION; INHIBITOR;
D O I
10.1155/2021/6675208
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The transforming growth factor-beta (TGF-beta) signaling pathway mediates various biological functions, and its dysregulation is closely related to the occurrence of malignant tumors. However, the role of TGF-beta signaling in tumorigenesis and development is complex and contradictory. On the one hand, TGF-beta signaling can exert antitumor effects by inhibiting proliferation or inducing apoptosis of cancer cells. On the other hand, TGF-beta signaling may mediate oncogene effects by promoting metastasis, angiogenesis, and immune escape. This review summarizes the recent findings on molecular mechanisms of TGF-beta signaling. Specifically, this review evaluates TGF-beta ' s therapeutic potential as a target by the following perspectives: ligands, receptors, and downstream signaling. We hope this review can trigger new ideas to improve the current clinical strategies to treat tumors related to the TGF-beta signaling pathway.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
    Lin, Mengmeng
    Li, Yingying
    Wang, Shiyuan
    Cao, Bo
    Li, Chunyu
    Li, Guohui
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [22] Processing of CD109 by furin and its role in the regulation of TGF-β signaling
    Hagiwara, S.
    Murakumo, Y.
    Mii, S.
    Shigetomi, T.
    Yamamoto, N.
    Furue, H.
    Ueda, M.
    Takahashi, M.
    ONCOGENE, 2010, 29 (15) : 2181 - 2191
  • [23] Overlapping activities of TGF-β and Hedgehog signaling in cancer: Therapeutic targets for cancer treatment
    Perrot, Carole Y.
    Javelaud, Delphine
    Mauviel, Alain
    PHARMACOLOGY & THERAPEUTICS, 2013, 137 (02) : 183 - 199
  • [24] Targeting TGF-β signaling in cancer
    Katz, Lior H.
    Li, Ying
    Chen, Jiun-Sheng
    Munoz, Nina M.
    Majumdar, Avijit
    Chen, Jian
    Mishra, Lopa
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 743 - 760
  • [25] TGF-β signaling in cancer metastasis
    Xie, Feng
    Ling, Li
    van Dam, Hans
    Zhou, Fangfang
    Zhang, Long
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2018, 50 (01) : 121 - 132
  • [26] TGF-β Family Signaling Pathways in Cellular Dormancy
    Prunier, Chloe
    Baker, David
    ten Dijke, Peter
    Ritsma, Laila
    TRENDS IN CANCER, 2019, 5 (01): : 66 - 78
  • [27] Non-Smad pathways in TGF-β signaling
    Zhang, Ying E.
    CELL RESEARCH, 2009, 19 (01) : 128 - 139
  • [28] Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
    Lecarpentier, Yves
    Gourrier, Elizabeth
    Gobert, Vincent
    Vallee, Alexandre
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [29] TGF-β as a therapeutic target in high grade gliomas - Promises and challenges
    Joseph, Justin V.
    Balasubramaniyan, Veerakumar
    Walenkamp, Annemiek
    Kruyt, Frank A. E.
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (04) : 478 - 485
  • [30] Differential TGF-β Signaling in Retinal Vascular Cells: A Role in Diabetic Retinopathy?
    Van Geest, Rob J.
    Klaassen, Ingeborg
    Vogels, Ilse M. C.
    Van Noorden, Cornelis J. F.
    Schlingemann, Reinier O.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (04) : 1857 - 1865